Articles Vol. 67 No. CĐ6-NCKH 16/06/2026

RESULTS OF BOTULINUM TOXIN A INJECTION COMBINED WITH PHYSICAL THERAPY IN REHABILITATION FOR STROKE PATIENTS WITH LOWER LIMB SPASTICITY

Tran Viet Ha1, Luong Tuan Khanh1
1 Bệnh viện Bạch Mai
DOI: 10.52163/yhc.v67iCD6.5295
34 Views
0 Downloads
Keywords
Botulinum toxin, lower-limb spasticity, stroke.
Abstract

Objective: To evaluate the outcomes of Botulinum toxin type A injection combined with therapeutic exercise in functional rehabilitation for stroke patients with lower-limb spasticity.

Subjects and methods: This prospective, uncontrolled interventional study was conducted at the Rehabilitation Center of Bach Mai Hospital over a one-year period (from October 2024 to October 2025) in 24 patients with a confirmed diagnosis of hemiplegia due to stroke and moderate to severe lower-limb spasticity. The modified Ashworth scale (MAS) was used to assess spasticity severity, the Tinetti scale was used to evaluate balance and gait, the TUGT was used to assess mobility and fall risk, and the LEFS was used to evaluate lower-limb function. Values were analyzed and compared before intervention and at 1 month and 3 months after intervention.

Results: After 1 month and 3 months of treatment, LEFS scores, Tinetti, TUGT, and MAS all showed significant improvement compared with baseline (p < 0.05).

Conclusion: Botulinum toxin type A injection combined with therapeutic exercise significantly improves lower-limb motor function, gait, and spasticity in patients after stroke.

References
[1]
Feigin V.L, Norrving B, Mensah G.A. Global Burden of Stroke. Circ Res, 2017, 120 (3): 439-448. doi: 10.1161/CIRCRESAHA.116.308413 Google Scholar
[2]
Geurts A.C.H, de Haart M, van Nes I.J.W, Duysens J. A review of standing balance recovery from stroke. Gait Posture, 2005, 22 (3): 267-281. doi: 10.1016/j.gaitpost.2004.10.002 Google Scholar
[3]
Sommerfeld D.K, Eek E.U.B, Svensson A.K, Holmqvist L.W, von Arbin M.H. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke, 2004, 35 (1): 134-139. doi: 10.1161/01.STR.0000105386.05173.5E Google Scholar
[4]
Watkins C.L, Leathley M.J, Gregson J.M, Moore A.P, Smith T.L, Sharma A.K. Prevalence of spasticity post stroke. Clin Rehabil, 2002, 16(5): 515-522. doi: 10.1191/0269215502cr512oa Google Scholar
[5]
Soyuer F, Oztürk A. The effect of spasticity, sense and walking aids in falls of people after chronic stroke. Disabil Rehabil, 2007, 29 (9): 679-687. doi: 10.1080/09638280600925860 Google Scholar
[6]
Yu H.X, Liu S.H, Wang Z.X, Liu C.B, Dai P, Zang D.W. Efficacy on gait and posture control after botulinum toxin A injection for lower-limb spasticity treatment after stroke: A randomized controlled trial. Front Neurosci, 2022, 16: 1107688. doi: 10.3389/fnins.2022.1107688 Google Scholar
[7]
Khan P, Riberto M, Frances JA, et al. The effectiveness of Botulinum toxin type A (BoNT-A) treatment in Brazilian patients with chronic post-stroke spasticity: results from the observational, multicenter, prospective BCause study. Toxins, 2020, 12 (12): 770. doi: 10.3390/toxins12120770 Google Scholar
[8]
Uchiyama Y, Koyama T, Wada Y, Katsutani M, Kodama N, Domen K. Botulinum toxin type a treatment combined with intensive rehabilitation for gait poststroke: a preliminary study. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc, 2018, 27 (7): 1975-1986. doi: 10.1016/j.jstrokecerebrovasdis.2018.02.054 Google Scholar